These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12584776)

  • 41. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
    Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
    J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis B vaccination in prison with a 3-week schedule is more efficient than the standard 6-month schedule.
    Christensen PB; Fisker N; Krarup HB; Liebert E; Jaroslavtsev N; Christensen K; Georgsen J
    Vaccine; 2004 Sep; 22(29-30):3897-901. PubMed ID: 15364437
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunogenicity of two paediatric doses of monovalent hepatitis B or combined hepatitis A and B vaccine in 8-10-year-old children.
    Duval B; Gîlca V; Boulianne N; Deceuninck G; Rochette L; De Serres G
    Vaccine; 2005 Jul; 23(31):4082-7. PubMed ID: 15963363
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis B boosters.
    Ide CW
    Occup Med (Lond); 2008 May; 58(3):222-3. PubMed ID: 18441364
    [No Abstract]   [Full Text] [Related]  

  • 45. Poly(propyleneimine) dendrimer and dendrosome mediated genetic immunization against hepatitis B.
    Dutta T; Garg M; Jain NK
    Vaccine; 2008 Jun; 26(27-28):3389-94. PubMed ID: 18511160
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protection provided by hepatitis B vaccine.
    Paul Y
    Indian Pediatr; 2001 Mar; 38(3):301-2. PubMed ID: 11255315
    [No Abstract]   [Full Text] [Related]  

  • 47. Long term antibody response to hepatitis B vaccination beginning at birth and to subsequent booster vaccination.
    Williams IT; Goldstein ST; Tufa J; Tauillii S; Margolis HS; Mahoney FJ
    Pediatr Infect Dis J; 2003 Feb; 22(2):157-63. PubMed ID: 12586980
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatitis B immunity in adolescents and necessity for boost vaccination: 23 years after nationwide hepatitis B virus vaccination program in Taiwan.
    Lu JJ; Cheng CC; Chou SM; Hor CB; Yang YC; Wang HL
    Vaccine; 2009 Nov; 27(47):6613-8. PubMed ID: 19698812
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A nested case control study for risk factors impacting hepatitis B vaccination in Hebei, China].
    Ma JC; Han CZ; Qi SX; Tian C; Li J; Zhao SJ; Zhang Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):201-4. PubMed ID: 19031703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of vaccination against viral hepatitis type B in children with the nephrotic syndrome.
    Szajner-Milart I; Zajaczkowska M; Zinkiewicz Z; Borzecka H; Majewski M
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):402-8. PubMed ID: 15315023
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunogenicity and safety of combined intradermal recombinant Hepatitis B with BCG vaccines at birth.
    Carniel EF; Morcillo AM; Blotta MH; Da Silva MT; Mazzola TN; Antonio MA; Zanolli ML; Netto AA; Higashi HG; Raw I; Vilela MM
    Vaccine; 2008 Jan; 26(5):647-52. PubMed ID: 18155811
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Persistence of immunity after hepatitis B vaccination].
    Madaliński K
    Przegl Epidemiol; 2002; 56(4):605-13. PubMed ID: 12666586
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
    González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
    Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatitis B control: lessons from the International Task Force on Hepatitis B Immunization and the Lombok Hepatitis B Model Immunization Project.
    Ruff TA; Muller N; Gust ID
    Prog Liver Dis; 1993; 11():179-201. PubMed ID: 8272510
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunogenicity and safety of an experimental adjuvanted hepatitis B candidate vaccine in liver transplant patients.
    Nevens F; Zuckerman JN; Burroughs AK; Jung MC; Bayas JM; Kallinowski B; Rivas EF; Duvoux C; Neuhaus P; Saliba F; Buti M; Zarski JP; Pons F; Vanlemmens C; Hamtiaux V; Stoffel M
    Liver Transpl; 2006 Oct; 12(10):1489-95. PubMed ID: 16964595
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of accelerated and rapid schedules for monovalent hepatitis B and combined hepatitis A/B vaccines in children with cancer.
    Köksal Y; Varan A; Aydin GB; Sari N; Yazici N; Yalcin B; Kutluk T; Akyuz C; Büyükpamukçu M
    Pediatr Hematol Oncol; 2007 Dec; 24(8):587-94. PubMed ID: 18092249
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Oral vaccines--a future prospect! Hepatitis vaccination in the vegetable market?].
    Stiefelhagen P
    MMW Fortschr Med; 2003 Nov; 145(47):10. PubMed ID: 14725025
    [No Abstract]   [Full Text] [Related]  

  • 58. Vaccination against hepatitis B in patients on chronic hemodialysis.
    Kovacic V; Sain M; Vukman V
    Saudi Med J; 2003 Mar; 24(3):311. PubMed ID: 12704514
    [No Abstract]   [Full Text] [Related]  

  • 59. Study of hepatitis B (HB) vaccine non-responsiveness among health care workers from an endemic area (Taiwan).
    Yen YH; Chen CH; Wang JH; Lee CM; Changchien CS; Lu SN
    Liver Int; 2005 Dec; 25(6):1162-8. PubMed ID: 16343067
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunisation against hepatitis B.
    Greensmith AL
    N Z Dent J; 1995 Jun; 91(404):69-70. PubMed ID: 7675351
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.